Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pacific Biosciences of California, Inc. - Common Stock (NQ:PACB)

1.385 +0.005 (+0.36%)
Streaming Delayed Price Updated: 2:22 PM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,700,607
Open 1.400
Bid (Size) 1.380 (6,600)
Ask (Size) 1.390 (8,900)
Prev. Close 1.380
Today's Range 1.310 - 1.440
52wk Range 1.085 - 2.730
Shares Outstanding 247,079,374
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Q1 Earnings Highs And Lows: PacBio (NASDAQ:PACB) Vs The Rest Of The Life Sciences Tools & Services Stocks
Looking back on life sciences tools & services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including PacBio (NASDAQ:PACB) and i... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Russell 2000 Stocks Walking a Fine Line
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,... 
Via StockStory

Performance

YTD
-24.7%
-24.7%
1 Month
+2.2%
+2.2%
3 Month
-0.4%
-0.4%
6 Month
-40.3%
-40.3%
1 Year
+15.4%
+15.4%

More News

Read More
News headline image
Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology
From Blank Bio
Via Business Wire
News headline image
1 Stock Under $10 to Keep an Eye On and 2 We Avoid
Via StockStory
News headline image
Why PacBio (PACB) Shares Are Getting Obliterated Today
Via StockStory
Topics Earnings Economy
News headline image
PacBio (PACB) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
PACB Q1 Deep Dive: Consumables Growth and Clinical Adoption Offset Instrument Weakness
Via StockStory
News headline image
Pacific Biosciences of California Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
3 Small-Cap Stocks We Find Risky
Via StockStory
Topics Artificial Intelligence
News headline image
PacBio (NASDAQ:PACB) Misses Q1 CY2026 Sales Expectations
Via StockStory
Topics Artificial Intelligence
News headline image
PacBio (PACB) Q1 Earnings Report Preview: What To Look For
Via StockStory
News headline image
1 Cash-Burning Stock with Solid Fundamentals and 2 We Turn Down
Via StockStory
News headline image
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know
Via StockStory
Topics Economy
News headline image
Ontario-Based DNAstack Leads Sovereign AI for Genomics and Health with Goal of Making Canadians Healthier and Reducing Strain on our Healthcare System
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know
Via StockStory
Topics Economy Government Stocks
News headline image
3 Small-Cap Stocks with Warning Signs
Via StockStory
Topics Artificial Intelligence
News headline image
Life Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders
Via StockStory
Topics Artificial Intelligence
News headline image
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know
Via StockStory
Topics Economy Stocks
News headline image
3 of Wall Street’s Favorite Stocks We Think Twice About
Via StockStory
Topics Economy
News headline image
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know
Via StockStory
Topics Economy
News headline image
Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB)
Via StockStory
Topics Artificial Intelligence
News headline image
3 Unprofitable Stocks We Approach with Caution
Via StockStory
News headline image
PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know
Via StockStory
Topics Economy Government Stocks
News headline image
The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026
Via MarketMinute
Topics Earnings Economy World Trade
News headline image
Why Is PacBio (PACB) Stock Soaring Today
Via StockStory
Topics Government Supply Chain World Trade

Frequently Asked Questions

Is Pacific Biosciences of California, Inc. - Common Stock publicly traded?
Yes, Pacific Biosciences of California, Inc. - Common Stock is publicly traded.
What exchange does Pacific Biosciences of California, Inc. - Common Stock trade on?
Pacific Biosciences of California, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pacific Biosciences of California, Inc. - Common Stock?
The ticker symbol for Pacific Biosciences of California, Inc. - Common Stock is PACB on the Nasdaq Stock Market
What is the current price of Pacific Biosciences of California, Inc. - Common Stock?
The current price of Pacific Biosciences of California, Inc. - Common Stock is 1.385
When was Pacific Biosciences of California, Inc. - Common Stock last traded?
The last trade of Pacific Biosciences of California, Inc. - Common Stock was at 06/09/26 02:22 PM ET
What is the market capitalization of Pacific Biosciences of California, Inc. - Common Stock?
The market capitalization of Pacific Biosciences of California, Inc. - Common Stock is 342.20M
How many shares of Pacific Biosciences of California, Inc. - Common Stock are outstanding?
Pacific Biosciences of California, Inc. - Common Stock has 342M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.